+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 14Years +
All Genders
ID04556188

Evaluating Cardiac Surgery Outcomes for Rheumatic Heart Disease and Anticoagulant Therapy Quality in Ethiopia and Norway

Led by Helse Nord-Trøndelag HF · Updated on 2025-06-12

200

Participants Needed

4

Research Sites

25 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate cardiac surgery outcomes for people with rheumatic heart disease RHD in Ethiopia, a low-income country. It compares the short- and long-term results of those who receive surgery with individuals who do not, due to limited access to cardiac surgery services. The study also examines the quality of anticoagulant therapy after surgery, assessing complications and treatment effectiveness compared to patients in Norway. The study observes three groups RHD patients undergoing cardiac surgery at Addis Abeba University Hospital, RHD patients who are not offered surgery, and Norwegian patients receiving anticoagulant therapy after valve replacement. Follow-up lasts 180 days for surgery outcomes, with ongoing monitoring of anticoagulation quality. Researchers look at mortality and complications such as heart failure, arrhythmias, thrombosis, bleeding, stroke, and infections. Participants will be monitored through clinical assessments and echocardiographic evaluations. The study tracks the time patients spend within therapeutic INR levels and records complications related to valve function and anticoagulant use. Outcome measures focus on short-term results at 180 days and longer-term anticoagulation quality. The study began in 2016 and will continue until 2026, involving matched control groups for comparison.

CONDITIONS

Brief Title

The Clinical Influence of Developing a Sustainable Cardiac Surgery Service to Reduce the Burden of Rheumatic Heart Disease in Sub-Saharan Africa

Research Team

H

Haavard Dalen, MD, PhD

R

Rune Haaverstad, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here